The TRAIL/TRAIL-R system is known to exert both pro- and anti-tumor activities via immune modulation involving both endogenous and exogenous TRAIL signaling in the tumor microenvironment [42,226,227,228]. This evidence concerns the gene TNFSF10 and neoplasm.